Cargando…

Preferential HLA-B27 Allorecognition Displayed by Multiple Cross-Reactive Antiviral CD8(+) T Cell Receptors

T cells provide essential immunosurveillance to combat and eliminate infection from pathogens, yet these cells can also induce unwanted immune responses via T cell receptor (TCR) cross-reactivity, also known as heterologous immunity. Indeed, pathogen-induced TCR cross-reactivity has shown to be a co...

Descripción completa

Detalles Bibliográficos
Autores principales: Rowntree, Louise C., van den Heuvel, Heleen, Sun, Jessica, D'Orsogna, Lloyd J., Nguyen, Thi H. O., Claas, Frans H. J., Rossjohn, Jamie, Kotsimbos, Tom C., Purcell, Anthony W., Mifsud, Nicole A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042382/
https://www.ncbi.nlm.nih.gov/pubmed/32140156
http://dx.doi.org/10.3389/fimmu.2020.00248
_version_ 1783501299057164288
author Rowntree, Louise C.
van den Heuvel, Heleen
Sun, Jessica
D'Orsogna, Lloyd J.
Nguyen, Thi H. O.
Claas, Frans H. J.
Rossjohn, Jamie
Kotsimbos, Tom C.
Purcell, Anthony W.
Mifsud, Nicole A.
author_facet Rowntree, Louise C.
van den Heuvel, Heleen
Sun, Jessica
D'Orsogna, Lloyd J.
Nguyen, Thi H. O.
Claas, Frans H. J.
Rossjohn, Jamie
Kotsimbos, Tom C.
Purcell, Anthony W.
Mifsud, Nicole A.
author_sort Rowntree, Louise C.
collection PubMed
description T cells provide essential immunosurveillance to combat and eliminate infection from pathogens, yet these cells can also induce unwanted immune responses via T cell receptor (TCR) cross-reactivity, also known as heterologous immunity. Indeed, pathogen-induced TCR cross-reactivity has shown to be a common, robust, and functionally potent mechanism that can trigger a spectrum of human immunopathologies associated with either transplant rejection, drug allergy, and autoimmunity. Here, we report that several virus-specific CD8(+) T cells directed against peptides derived from chronic viruses (EBV, CMV, and HIV-1) presented by high frequency HLA-A and -B allomorphs differentially cross-react toward HLA-B27 allotypes in a highly focused and hierarchical manner. Given the commonality of cross-reactive T cells and their potential contribution to adverse outcomes in allogeneic transplants, our study demonstrates that multiple antiviral T cells recognizing the same HLA allomorph could pose an extra layer of complexity for organ matching.
format Online
Article
Text
id pubmed-7042382
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-70423822020-03-05 Preferential HLA-B27 Allorecognition Displayed by Multiple Cross-Reactive Antiviral CD8(+) T Cell Receptors Rowntree, Louise C. van den Heuvel, Heleen Sun, Jessica D'Orsogna, Lloyd J. Nguyen, Thi H. O. Claas, Frans H. J. Rossjohn, Jamie Kotsimbos, Tom C. Purcell, Anthony W. Mifsud, Nicole A. Front Immunol Immunology T cells provide essential immunosurveillance to combat and eliminate infection from pathogens, yet these cells can also induce unwanted immune responses via T cell receptor (TCR) cross-reactivity, also known as heterologous immunity. Indeed, pathogen-induced TCR cross-reactivity has shown to be a common, robust, and functionally potent mechanism that can trigger a spectrum of human immunopathologies associated with either transplant rejection, drug allergy, and autoimmunity. Here, we report that several virus-specific CD8(+) T cells directed against peptides derived from chronic viruses (EBV, CMV, and HIV-1) presented by high frequency HLA-A and -B allomorphs differentially cross-react toward HLA-B27 allotypes in a highly focused and hierarchical manner. Given the commonality of cross-reactive T cells and their potential contribution to adverse outcomes in allogeneic transplants, our study demonstrates that multiple antiviral T cells recognizing the same HLA allomorph could pose an extra layer of complexity for organ matching. Frontiers Media S.A. 2020-02-19 /pmc/articles/PMC7042382/ /pubmed/32140156 http://dx.doi.org/10.3389/fimmu.2020.00248 Text en Copyright © 2020 Rowntree, van den Heuvel, Sun, D'Orsogna, Nguyen, Claas, Rossjohn, Kotsimbos, Purcell and Mifsud. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Rowntree, Louise C.
van den Heuvel, Heleen
Sun, Jessica
D'Orsogna, Lloyd J.
Nguyen, Thi H. O.
Claas, Frans H. J.
Rossjohn, Jamie
Kotsimbos, Tom C.
Purcell, Anthony W.
Mifsud, Nicole A.
Preferential HLA-B27 Allorecognition Displayed by Multiple Cross-Reactive Antiviral CD8(+) T Cell Receptors
title Preferential HLA-B27 Allorecognition Displayed by Multiple Cross-Reactive Antiviral CD8(+) T Cell Receptors
title_full Preferential HLA-B27 Allorecognition Displayed by Multiple Cross-Reactive Antiviral CD8(+) T Cell Receptors
title_fullStr Preferential HLA-B27 Allorecognition Displayed by Multiple Cross-Reactive Antiviral CD8(+) T Cell Receptors
title_full_unstemmed Preferential HLA-B27 Allorecognition Displayed by Multiple Cross-Reactive Antiviral CD8(+) T Cell Receptors
title_short Preferential HLA-B27 Allorecognition Displayed by Multiple Cross-Reactive Antiviral CD8(+) T Cell Receptors
title_sort preferential hla-b27 allorecognition displayed by multiple cross-reactive antiviral cd8(+) t cell receptors
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042382/
https://www.ncbi.nlm.nih.gov/pubmed/32140156
http://dx.doi.org/10.3389/fimmu.2020.00248
work_keys_str_mv AT rowntreelouisec preferentialhlab27allorecognitiondisplayedbymultiplecrossreactiveantiviralcd8tcellreceptors
AT vandenheuvelheleen preferentialhlab27allorecognitiondisplayedbymultiplecrossreactiveantiviralcd8tcellreceptors
AT sunjessica preferentialhlab27allorecognitiondisplayedbymultiplecrossreactiveantiviralcd8tcellreceptors
AT dorsognalloydj preferentialhlab27allorecognitiondisplayedbymultiplecrossreactiveantiviralcd8tcellreceptors
AT nguyenthiho preferentialhlab27allorecognitiondisplayedbymultiplecrossreactiveantiviralcd8tcellreceptors
AT claasfranshj preferentialhlab27allorecognitiondisplayedbymultiplecrossreactiveantiviralcd8tcellreceptors
AT rossjohnjamie preferentialhlab27allorecognitiondisplayedbymultiplecrossreactiveantiviralcd8tcellreceptors
AT kotsimbostomc preferentialhlab27allorecognitiondisplayedbymultiplecrossreactiveantiviralcd8tcellreceptors
AT purcellanthonyw preferentialhlab27allorecognitiondisplayedbymultiplecrossreactiveantiviralcd8tcellreceptors
AT mifsudnicolea preferentialhlab27allorecognitiondisplayedbymultiplecrossreactiveantiviralcd8tcellreceptors